全文获取类型
收费全文 | 2126篇 |
免费 | 114篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 116篇 |
妇产科学 | 24篇 |
基础医学 | 224篇 |
口腔科学 | 28篇 |
临床医学 | 167篇 |
内科学 | 456篇 |
皮肤病学 | 39篇 |
神经病学 | 89篇 |
特种医学 | 79篇 |
外科学 | 286篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 142篇 |
眼科学 | 146篇 |
药学 | 182篇 |
中国医学 | 7篇 |
肿瘤学 | 204篇 |
出版年
2023年 | 18篇 |
2022年 | 47篇 |
2021年 | 75篇 |
2020年 | 36篇 |
2019年 | 51篇 |
2018年 | 67篇 |
2017年 | 35篇 |
2016年 | 50篇 |
2015年 | 73篇 |
2014年 | 74篇 |
2013年 | 78篇 |
2012年 | 154篇 |
2011年 | 134篇 |
2010年 | 84篇 |
2009年 | 87篇 |
2008年 | 120篇 |
2007年 | 142篇 |
2006年 | 91篇 |
2005年 | 78篇 |
2004年 | 84篇 |
2003年 | 82篇 |
2002年 | 69篇 |
2001年 | 41篇 |
2000年 | 50篇 |
1999年 | 42篇 |
1998年 | 16篇 |
1997年 | 20篇 |
1996年 | 24篇 |
1995年 | 11篇 |
1994年 | 11篇 |
1993年 | 13篇 |
1992年 | 37篇 |
1991年 | 22篇 |
1990年 | 19篇 |
1989年 | 14篇 |
1988年 | 16篇 |
1987年 | 13篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1972年 | 12篇 |
1971年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有2251条查询结果,搜索用时 0 毫秒
121.
122.
123.
124.
Shanmugam MP Biswas J Gopal L Sharma T Nizamuddin SH 《Journal of pediatric ophthalmology and strabismus》2005,42(2):75-81; quiz 112-3
PURPOSE: To study the clinical spectrum and treatment outcome of retinoblastoma in Indian children. PATIENTS AND METHODS: This retrospective study analyzed 488 eyes of 355 retinoblastoma patients treated at a tertiary care ophthalmic hospital in southern India during a 14-year period. RESULTS: Retinoblastoma involved one eye in 177 (50%) and both eyes in 178 (50%) patients. Mean age at presentation was 23.98 +/- 23.37. 相似文献
125.
Gopal L Babu EK Gupta S Krishnakumar S Biswas J Rao NA 《Journal of pediatric ophthalmology and strabismus》2004,41(6):364-366
Medulloepitheliomas are usually amelanotic. Pigmented medulloepitheliomas are unusual and only two cases have been reported. We report an additional case of pigmented malignant medulloepithelioma of the ciliary body with histopathologic correlation. 相似文献
126.
Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms 总被引:4,自引:0,他引:4 下载免费PDF全文
OBJECTIVE: To determine whether the presence of laryngopharyngeal reflux symptoms is associated with the presence of esophageal adenocarcinoma (EAC). BACKGROUND: Most patients diagnosed with EAC have incurable disease at the time of detection. The majority of these patients are unaware of the presence of Barrett's esophagus prior to cancer diagnosis and many do not report typical symptoms of gastroesophageal reflux disease (GERD). This suggests that the current GERD symptom-based screening paradigm may be inadequate. Data support a causal relation between complicated GERD and laryngopharyngeal reflux symptoms. We theorize that laryngopharyngeal reflux symptoms are not recognized expeditiously, resulting in chronic esophageal injury and an unrecognized progression of Barrett's esophagus to EAC. METHODS: This is a case-comparison (control) study. Cases were patients diagnosed with EAC (n = 63) between 1997 and 2002. Three comparison groups were selected: 1) Barrett's esophagus patients without dysplasia (n = 50), 2) GERD patients without Barrett's esophagus (n = 50), and 3) patients with no history of GERD symptoms or antisecretory medication use (n = 56). The risk factors evaluated included demographics, medical history, lifestyle variables, and laryngopharyngeal reflux symptoms. Typical GERD symptoms and antisecretory medication use were recorded. Multivariate analysis of demographics, comorbid risk factors, and symptoms was performed with logistic regression to provide odds ratios for the probability of EAC diagnosis. RESULTS: The prevalence of patients with laryngopharyngeal reflux symptoms was significantly greater in the cases than comparison groups (P = 0.0005). The prevalence of laryngopharyngeal reflux symptoms increased as disease severity progressed from the non-GERD comparison group (19.6%) to GERD (26%), Barrett's esophagus (40%), and EAC patients (54%). Symptoms of GERD were less prevalent in cases (43%) when compared with Barrett's esophagus (66%) and GERD (86%) control groups (P < 0.001). Twenty-seven percent (17 of 63) of EAC patients never had GERD or laryngopharyngeal reflux symptoms. Fifty-seven percent of EAC patients presented without ever having typical GERD symptoms. Chronic cough, diabetes, and age emerged as independent risk factors for the development of EAC. CONCLUSIONS: Symptoms of laryngopharyngeal reflux are more prevalent in patients with EAC than typical GERD symptoms and may represent the only sign of disease. Chronic cough is an independent risk factor associated with the presence of EAC. Addition of laryngopharyngeal reflux symptoms to the current Barrett's screening guidelines is warranted. 相似文献
127.
Short-term outcome analysis of total pelvic reconstruction with mesh: the vaginal approach 总被引:5,自引:0,他引:5
PURPOSE: We describe our experience with transvaginal total pelvic reconstruction using a mesh with 4-point fixation for patients with genitourinary prolapse with or without stress urinary incontinence. MATERIALS AND METHODS: A total of 29 consecutive patients who underwent sacrospinous fixation using mesh material since March 1999 for genitourinary prolapse were analyzed retrospectively. In all patients defect specific repair was done, including hysterectomy (in 13). For isolated vault prolapse a rectangular mesh was interposed between the peritoneum and vaginal vault, with each corner anchored to the sacrospinous ligament using a suture-capturing device. For vault prolapse associated with anterior vaginal wall prolapse an "H" shaped, 1-piece sling was used to support both entities. Additionally, posterior and perineal repairs were done through separate incisions if needed. RESULTS: Of the 29 patients 19 (65.5%), 7 (26.92%) and 11 (39.29%) had associated symptoms of stress urinary incontinence, urgency and frequency, respectively, and 79.31% had associated anterior and 44.8% had associated posterior prolapse. Average operative time was 175.6 minutes, blood loss was 340 cc and hospital stay was 2.46 days. Early adverse events following the procedure were perineal pain, vaginal discharge and irritative voiding symptoms. At 6 month followup (mean 25.14 months) mild constipation and dyspareunia were encountered in a small subset of patients. Two patients (6.89%) have genital prolapse recurrence and none has reported erosion or nonhealing to date. CONCLUSIONS: Transvaginal technique of 4-point vaginal vault fixation using mesh is a safe and effective procedure at 2 years. 相似文献
128.
129.
Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells 总被引:9,自引:0,他引:9
There is an emerging evidence that plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) may have potential as a chemotherapeutic agent. However, the growth inhibitory mechanisms of plumbagin have remained unexplored. The aim of the study was to determine whether plumbagin-induced cell death in human cervical cancer cell line, ME-180, exhibited biochemical characteristics of apoptosis and to check whether N-acetyl-l-cysteine (NAC), which is a free radical scavenger, can reverse the cytotoxic effects of plumbagin. It can be concluded from the results that plumbagin inhibits the growth of ME-180 cells in a concentration and time-dependent manner. The cytotoxic effect of plumbagin induced cell death is through the generation of reactive oxygen species (ROS) and subsequent induction of apoptosis as demonstrated by the present data. Treatment of cells with plumbagin caused loss of mitochondrial membrane potential (DeltaPsi(m)), and morphological changes characteristic of apoptosis, such as the translocation of phosphatidyl serine, nuclear condensation, and DNA fragmentation. Moreover, plumbagin-induced apoptosis involved release of mitochondrial cytochrome c and apoptosis inducing factor (AIF), thus activation of caspase-dependent and -independent pathways, as shown by the plumbagin-mediated activation of caspase-3 and -9. Our results also show that pretreatment of ME-180 cells with NAC blocks plumbagin-induced loss of DeltaPsi(m) and subsequent release of cytochrome c, AIF, and caspase-9 and -3 activation, thus inhibiting the apoptotic ability of plumbagin. 相似文献
130.